- Home
- HCWB vs GNS Comparison
HCWB vs GNS Comparison
Compare HCWB & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- GNS
- Stock Information
- Founded
- HCWB 2018
- GNS 2002
- Country
- HCWB United States
- GNS Singapore
- Employees
- HCWB N/A
- GNS N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- GNS Other Consumer Services
- Sector
- HCWB Health Care
- GNS Real Estate
- Exchange
- HCWB Nasdaq
- GNS Nasdaq
- Market Cap
- HCWB 16.1M
- GNS 17.8M
- IPO Year
- HCWB 2021
- GNS 2022
- Fundamental
- Price
- HCWB $6.14
- GNS $0.38
- Analyst Decision
- HCWB Strong Buy
- GNS
- Analyst Count
- HCWB 1
- GNS 0
- Target Price
- HCWB $35.00
- GNS N/A
- AVG Volume (30 Days)
- HCWB 2.0M
- GNS 4.4M
- Earning Date
- HCWB 05-15-2025
- GNS 04-30-2025
- Dividend Yield
- HCWB N/A
- GNS N/A
- EPS Growth
- HCWB N/A
- GNS N/A
- EPS
- HCWB N/A
- GNS N/A
- Revenue
- HCWB $1,445,145.00
- GNS $7,912,718.00
- Revenue This Year
- HCWB N/A
- GNS $233.65
- Revenue Next Year
- HCWB N/A
- GNS $570.20
- P/E Ratio
- HCWB N/A
- GNS N/A
- Revenue Growth
- HCWB N/A
- GNS N/A
- 52 Week Low
- HCWB $5.00
- GNS $0.21
- 52 Week High
- HCWB $100.80
- GNS $3.37
- Technical
- Relative Strength Index (RSI)
- HCWB 36.95
- GNS 56.32
- Support Level
- HCWB $7.55
- GNS $0.30
- Resistance Level
- HCWB $8.75
- GNS $0.33
- Average True Range (ATR)
- HCWB 0.85
- GNS 0.04
- MACD
- HCWB -0.14
- GNS -0.00
- Stochastic Oscillator
- HCWB 4.60
- GNS 58.62
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.